<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Support Care Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Support Care Cancer</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Supportive Care in Cancer</journal-title></journal-title-group><issn pub-type="ppub">0941-4355</issn><issn pub-type="epub">1433-7339</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11535011</article-id><article-id pub-id-type="pmcid-ver">PMC11535011.1</article-id><article-id pub-id-type="pmcaid">11535011</article-id><article-id pub-id-type="pmcaiid">11535011</article-id><article-id pub-id-type="pmid">39496999</article-id><article-id pub-id-type="doi">10.1007/s00520-024-08968-4</article-id><article-id pub-id-type="publisher-id">8968</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Patterns of patient-reported outcomes (PROs) in a diverse group of gynecologic cancer survivors</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gerrity</surname><given-names initials="C">Charlotte</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sinno</surname><given-names initials="A">Abdulrahman</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Natori</surname><given-names initials="A">Akina</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sookdeo</surname><given-names initials="V">Vandana</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>MacIntyre</surname><given-names initials="J">Jessica</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>George</surname><given-names initials="S">Sophia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Calfa</surname><given-names initials="C">Carmen</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Crane</surname><given-names initials="TE">Tracy E.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Penedo</surname><given-names initials="FJ">Frank J.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Schlumbrecht</surname><given-names initials="M">Matthew</given-names></name><address><email>mschlumbrecht@miami.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dgjyy92</institution-id><institution-id institution-id-type="GRID">grid.26790.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8606</institution-id><institution>Department of Obstetrics, Gynecology, and Reproductive Sciences, </institution><institution>University of Miami Miller School of Medicine, </institution></institution-wrap>Miami, FL USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0552r4b12</institution-id><institution-id institution-id-type="GRID">grid.419791.3</institution-id><institution-id institution-id-type="ISNI">0000 0000 9902 6374</institution-id><institution>Sylvester Comprehensive Cancer Center, </institution></institution-wrap>1121 NW 14th St, Suite 345C, Miami, FL 33136 USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dgjyy92</institution-id><institution-id institution-id-type="GRID">grid.26790.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8606</institution-id><institution>Department of Medicine, </institution><institution>University of Miami Miller School of Medicine, </institution></institution-wrap>Miami, FL USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dgjyy92</institution-id><institution-id institution-id-type="GRID">grid.26790.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8606</institution-id><institution>Department of Psychology, </institution><institution>University of Miami, </institution></institution-wrap>Miami, FL USA </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>32</volume><issue>11</issue><issue-id pub-id-type="pmc-issue-id">474333</issue-id><elocation-id>771</elocation-id><history><date date-type="received"><day>19</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>04</day><month>11</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>06</day><month>11</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-15 05:25:20.583"><day>15</day><month>11</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="520_2024_Article_8968.pdf"/><abstract id="Abs1"><sec><title>Objectives</title><p id="Par1">Racial and ethnic disparities in patient-reported outcomes (PROs) among gynecologic cancer survivors are not well studied. We evaluated whether individual-level characteristics were associated with PROs in diverse gynecologic cancer survivors.</p></sec><sec><title>Methods</title><p id="Par2">Gynecologic cancer patients in an ambulatory oncology clinic completed a psychosocial and practical needs assessment before their appointments through the electronic medical record (EMR) patient portal. Assessments were available in English and Spanish. Fatigue, pain, physical function, depression, and anxiety were assessed with Patient-Reported Outcomes Measurement Information System (PROMIS&#174;) computer adaptive tests, and health-related quality of life was assessed by FACT-G7. PROs were dichotomized based on severity (normal/mild vs moderate/severe). Demographic and clinical information was collected. Analyses were performed using Chi-square, t-tests, and Kruskal&#8211;Wallis tests.</p></sec><sec><title>Results</title><p id="Par3">A total of 582 women completed the assessment; 20% (<italic toggle="yes">n</italic>&#8201;=&#8201;116) were racial minorities, and 54.5% (<italic toggle="yes">n</italic>&#8201;=&#8201;310) were Hispanic. A total of 192 (32.8%) completed the assessments in Spanish. Hispanic patients had lower mean fatigue scores (49.31 vs 51.74, <italic toggle="yes">p</italic>&#8201;=&#8201;0.01), and patients whose preferred language was Spanish had lower mean depression (47.63 vs 48.97, <italic toggle="yes">p</italic>&#8201;=&#8201;0.05) and fatigue scores (48.27 vs 51.27, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01). There were no significant differences in the severity of PROs by race, ethnicity, or preferred language. QOL scores were worse in patients with high symptom severity for anxiety (<italic toggle="yes">p</italic>&#8201;=&#8201;0.04) and physical functioning (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01). Current smokers had worse physical functioning (13.4% vs 6.5%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.03).</p></sec><sec><title>Conclusions</title><p id="Par4">We found no significant differences in severity of PROs by race, ethnicity, or preferred language. Quality of life scores were worse for patients with high symptom severity for physical functioning and anxiety.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00520-024-08968-4.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Patient-reported outcomes</kwd><kwd>Gynecologic cancer</kwd><kwd>Hispanic</kwd></kwd-group><funding-group><award-group><funding-source><institution>National Cancer Institute (United States)</institution></funding-source><award-id>P30 CA240139</award-id><award-id>P30 CA240139</award-id><award-id>P30 CA240139</award-id><award-id>P30 CA240139</award-id><award-id>P30 CA240139</award-id><award-id>P30 CA240139</award-id><award-id>P30 CA240139</award-id><award-id>P30 CA240139</award-id><award-id>P30 CA240139</award-id><principal-award-recipient><name name-style="western"><surname>Sinno</surname><given-names>Abdulrahman</given-names></name><name name-style="western"><surname>Natori</surname><given-names>Akina</given-names></name><name name-style="western"><surname>Sookdeo</surname><given-names>Vandana</given-names></name><name name-style="western"><surname>MacIntyre</surname><given-names>Jessica</given-names></name><name name-style="western"><surname>George</surname><given-names>Sophia</given-names></name><name name-style="western"><surname>Calfa</surname><given-names>Carmen</given-names></name><name name-style="western"><surname>Crane</surname><given-names>Tracy E.</given-names></name><name name-style="western"><surname>Penedo</surname><given-names>Frank J.</given-names></name><name name-style="western"><surname>Schlumbrecht</surname><given-names>Matthew</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Patient-reported outcomes (PROs) measure symptoms, quality of life, and overall functioning directly from the patient without interpretation by a provider [<xref ref-type="bibr" rid="CR1">1</xref>]. Routine collection of PROs allows for better patient-provider communication and can facilitate early identification of intolerable symptoms associated with treatment, urgent psychosocial concerns, and other cancer-related complications [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. This improved identification of patient needs and concerns can guide treatment decisions and connect patients to essential services that may improve survival [<xref ref-type="bibr" rid="CR2">2</xref>]. Analysis of PROs within specific subpopulations may enhance understanding of the needs and lived experience of cancer survivors of differing disease sites [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par6">To date, most studies of PROs in gynecologic cancer survivors, and cancer survivors in general, have been conducted in populations with an overwhelming majority of White, English-speaking patients [<xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref>]. The results of these studies have limited generalizability to clinical settings with more diverse patient populations. Hispanic and Spanish-speaking patients are particularly underrepresented in studies of PROs in patients with gynecologic cancer, yet they represent a growing population in the USA [<xref ref-type="bibr" rid="CR8">8</xref>]. Philp et al. found that Black and Hispanic patients had less emotional and instrumental support relative to their White counterparts while undergoing evaluation or treatment for gynecologic cancers [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par7">Racial and ethnic disparities have been identified in all gynecologic cancers at multiple levels of influence [<xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR13">13</xref>]. Black women of any ethnicity experience the most profound disparities relative to other races [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. They have the highest mortality and lowest 5-year survival of all races for cervix cancer regardless of stage at diagnosis or histologic subtype [<xref ref-type="bibr" rid="CR9">9</xref>]. They also have the highest risk of endometrial cancer of all races and are more likely to present with a high-risk histologic subtype [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Black women with endometrial cancer experience more treatment delays, receive less guideline-adherent care, and are less likely to receive referrals to essential supportive care services [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR14">14</xref>]. Hispanic patients are more likely to present with advanced-stage cervix and endometrial cancer [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], less likely to receive standard-of-care treatment for ovarian and endometrial cancer [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>], more likely to experience treatment delays, and less likely to have surgery at a high-volume surgical center [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>]. There are also known disparities in health-related quality of life (QOL) and higher unmet supportive care needs among Hispanic and Latino cancer survivors [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par8">Given known disparities in gynecologic care among racial and ethnic minorities, as well as the lack of data in these populations relative to self-reported symptom burden, our objective was to complete an exploratory analysis to characterize PROs by race, ethnicity, and preferred language in a diverse group of gynecologic cancer survivors and assess their relationships with overall QOL. We hypothesized that PROs would vary by patient demographics and that there would be substantial variation in the context of patient race and ethnicity.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Procedures</title><p id="Par9">In 2019, the ambulatory Gynecologic Oncology clinic at the University of Miami Sylvester Comprehensive Cancer Center (SCCC) implemented a symptom monitoring program through the electronic health record to assess symptoms and needs before appointments and triage patients to supportive care services [<xref ref-type="bibr" rid="CR7">7</xref>]. Patients presenting for their second or later visit are prompted to complete a wellness assessment called My Wellness Check (MWC) through Epic MyChart before each appointment. Patients are not prompted to complete the evaluation at the first visit, which typically focuses on diagnosis and treatment planning; this visit can create high levels of stress and anxiety that tend to resolve over time. The decision to exclude patients on the first visit was made at the discretion of SCCC leadership. Assessments are available in English and Spanish and take approximately 8&#8211;10&#160;min to complete online or in the Epic MyChart patient portal. Patients are prompted to complete the assessment 72&#160;h before each appointment, and patients with frequent appointments are not prompted to complete the survey more than once every 30&#160;days. This research protocol was approved under the University of Miami Institutional Review Board (ID 20220248), with a waiver of consent granted, and was conducted in accordance with the Declaration of Helsinki.</p></sec><sec id="Sec4"><title>Questionnaires</title><p id="Par10">The primary measure used for symptom monitoring is Patient-Reported Outcomes Measurement Information System (PROMIS&#174;) Computer Adaptive Tests (CATs), a series of brief, validated symptom questionnaires widely used in ambulatory oncology settings [<xref ref-type="bibr" rid="CR21">21</xref>&#8211;<xref ref-type="bibr" rid="CR24">24</xref>]. PROMIS&#174; CATs generate T-scores and corresponding severity thresholds (normal, mild, moderate, or severe (Supplement <xref rid="MOESM1" ref-type="media">1</xref>) using normative data from patients with cancer and the general population, with 50 being the mean T-score and a standard deviation of 10 in the reference population [<xref ref-type="bibr" rid="CR7">7</xref>]. Patients are prompted to complete PROMIS&#174; CATs for depression, anxiety, fatigue, pain interference, and physical function. Patients are also reminded to complete the FACT-G7, a seven-item validated questionnaire that assesses the most important symptoms and concerns commonly reported by patients undergoing cancer treatment [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par11">Demographic information, including age (continuous), race (White, Black, Other), ethnicity (Hispanic, non-Hispanic), preferred language (English, Spanish), marital status (married, divorced, widowed, single), insurance status (private insurance, government insurance, self-pay), alcohol use (yes/no), and smoking history (never/former vs current), was collected from the EMR. Clinical data, including cancer type (ovary, cervix, endometrium, or other), recurrence (yes/no), and time since diagnosis, were also gathered from the EMR. Stage was excluded as a variable given the significant heterogeneity of the population with regard to disease site, staging schemas, and treatment trajectories.</p><p id="Par12">All patients who completed the MWC PROMIS&#174; CATs between August 2019 and August 2021 were included. The most recently completed questionnaire was included in this analysis for each patient to avoid redundant input from the same patient. Patients who had incomplete PROs (no scores available) were excluded. Patients receiving care at our clinic who did not have a primary gynecologic cancer diagnosis were also excluded.</p></sec><sec id="Sec5"><title>Data analyses</title><p id="Par13">Statistical analyses were completed using STATA IC (StataCorp, College Station, TX). Descriptive statistics were used to summarize demographic and clinical characteristics. Hispanic ethnicity and Spanish-speaking were considered as separate variables for all analyses. Given the high rate of bilingualism in Miami-Dade County among Hispanic patients [<xref ref-type="bibr" rid="CR26">26</xref>], language preference is an inaccurate surrogate of ethnicity and was considered a separate variable. The t-test was used to compare means of raw PRO T-scores across according to patient-level factors. T-scores generated from PROs were dichotomized into two categories by severity threshold: low (normal&#8201;+&#8201;mild) vs high (moderate&#8201;+&#8201;severe) for comparisons among groups. Chi-square tests (or Fisher&#8217;s exact, if indicated) were then used to compare the proportions of high vs low severity responses by demographic factors. The Kruskal&#8211;Wallis test was used to compare overall quality of life (QOL) scores according to the dichotomized PROs. All tests were two-sided with significance set at <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05.</p></sec></sec><sec id="Sec6"><title>Results</title><p id="Par14">During the study interval, 582 women completed at least one assessment. Demographic characteristics are summarized in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. A total of 20% of patients (<italic toggle="yes">n</italic>&#8201;=&#8201;116) were racial minorities, and 54.5% (<italic toggle="yes">n</italic>&#8201;=&#8201;310) were of Hispanic ethnicity. One hundred ninety-two patients (32.8%) completed the assessments in Spanish. Of those women who identified as non-Hispanic, Spanish was the preferred language in 1.9%. Of those who identified as Hispanic, Spanish was the preferred language in 59.4% of respondents (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Median age at completion was 56.9&#160;years (range 18.2&#8211;92.8). All patients had a confirmed gynecologic cancer diagnosis, and 338 (63.8%) had recurrent disease. The most common cancer type was uterine (<italic toggle="yes">n</italic>&#8201;=&#8201;227, 39.0%), followed by ovary (<italic toggle="yes">n</italic>&#8201;=&#8201;201, 34.5%), cervix (<italic toggle="yes">n</italic>&#8201;=&#8201;98, 16.8%), and other (<italic toggle="yes">n</italic>&#8201;=&#8201;56, 9.7%). Most patients had health insurance (<italic toggle="yes">n</italic>&#8201;=&#8201;562, 96.6%).
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Patient demographics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2" rowspan="1">Demographic information</th></tr><tr><th align="left" colspan="2" rowspan="1"><italic toggle="yes">n</italic>&#8201;=&#8201;<italic toggle="yes">582 women with confirmed gynecologic cancer</italic></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Race</td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> White</td><td align="left" colspan="1" rowspan="1">458 (80%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Black</td><td align="left" colspan="1" rowspan="1">91 (16%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Other</td><td align="left" colspan="1" rowspan="1">33 (4%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Ethnicity</td></tr><tr><td align="left" colspan="1" rowspan="1"> Non-Hispanic</td><td align="left" colspan="1" rowspan="1">259 (45.5%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Hispanic</td><td align="left" colspan="1" rowspan="1">310 (54.5%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Preferred language</td></tr><tr><td align="left" colspan="1" rowspan="1"> English</td><td align="left" colspan="1" rowspan="1">390 (67.2%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Spanish</td><td align="left" colspan="1" rowspan="1">192 (32.8%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Marital status</td></tr><tr><td align="left" colspan="1" rowspan="1"> Married</td><td align="left" colspan="1" rowspan="1">313 (54.9%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Divorced</td><td align="left" colspan="1" rowspan="1">98 (17.2%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Single</td><td align="left" colspan="1" rowspan="1">122 (21.4%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Widowed</td><td align="left" colspan="1" rowspan="1">Widowed 37 (6.5%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Insurance status</td></tr><tr><td align="left" colspan="1" rowspan="1"> Private</td><td align="left" colspan="1" rowspan="1">432 (74.2%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Government</td><td align="left" colspan="1" rowspan="1">130 (22.3%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Self-pay</td><td align="left" colspan="1" rowspan="1">20 (3.5%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Alcohol use</td></tr><tr><td align="left" colspan="1" rowspan="1"> Yes</td><td align="left" colspan="1" rowspan="1">219 (37.6%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> No</td><td align="left" colspan="1" rowspan="1">363 (62.4%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Smoking</td></tr><tr><td align="left" colspan="1" rowspan="1"> Current/ever</td><td align="left" colspan="1" rowspan="1">160 (27.5%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Never</td><td align="left" colspan="1" rowspan="1">422 (72.5%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Primary site of disease</td></tr><tr><td align="left" colspan="1" rowspan="1"> Cervix</td><td align="left" colspan="1" rowspan="1">98 (16.8%),</td></tr><tr><td align="left" colspan="1" rowspan="1"> Uterus</td><td align="left" colspan="1" rowspan="1">227 (39.0%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ovary</td><td align="left" colspan="1" rowspan="1">201 (34.5%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Other</td><td align="left" colspan="1" rowspan="1">56 (9.7%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Disease course</td></tr><tr><td align="left" colspan="1" rowspan="1"> Primary treatment</td><td align="left" colspan="1" rowspan="1">244 (36.2%)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Recurrence</td><td align="left" colspan="1" rowspan="1">338 (63.8%)</td></tr></tbody></table></table-wrap></p><p id="Par15">Raw PRO scores relative to patient characteristics are shown in Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>. Hispanic patients had lower mean fatigue scores than non-Hispanics (49.31 vs 51.74, <italic toggle="yes">p</italic>&#8201;=&#8201;0.01). Relative to patients whose preferred language was English, patients whose preferred language was Spanish had lower mean depression (47.63 vs 48.97, <italic toggle="yes">p</italic>&#8201;=&#8201;0.05) and fatigue scores (48.27 vs 51.27, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01). Older age at diagnosis was associated with higher fatigue scores (<italic toggle="yes">p</italic>&#8201;=&#8201;0.048) but had no association with other PROs. Older age and government insurance coverage were associated with lower physical functioning (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Time since diagnosis and age at assessment completion were not associated with any PRO scores. There were no differences in any measures by race or by cancer site. All scores were poorer in patients who had recurred.
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Patient characteristics relative to self-reported scores for anxiety, depression, and fatigue</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variable</th><th align="left" colspan="1" rowspan="1">Anxiety (mean, SD)</th><th align="left" colspan="1" rowspan="1">Depression (mean, SD)</th><th align="left" colspan="1" rowspan="1">Fatigue (mean, SD)</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">Race</td></tr><tr><td align="left" colspan="1" rowspan="1"> White</td><td align="left" colspan="1" rowspan="1">53.19 (9.92)</td><td align="left" colspan="1" rowspan="1">48.24 (9.87)</td><td align="left" colspan="1" rowspan="1">50.17 (11.03)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Black</td><td align="left" colspan="1" rowspan="1">53.16 (9.16)</td><td align="left" colspan="1" rowspan="1">49.97 (9.59)</td><td align="left" colspan="1" rowspan="1">50.75 (11.24)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Other</td><td align="left" colspan="1" rowspan="1">51.77 (10.03)</td><td align="left" colspan="1" rowspan="1">48 (9.65)</td><td align="left" colspan="1" rowspan="1">50.8 (9.64)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.69</td><td align="left" colspan="1" rowspan="1">0.39</td><td align="left" colspan="1" rowspan="1">0.81</td></tr><tr><td align="left" colspan="4" rowspan="1">Ethnicity</td></tr><tr><td align="left" colspan="1" rowspan="1"> Non-Hispanic</td><td align="left" colspan="1" rowspan="1">53.00 (9.07)</td><td align="left" colspan="1" rowspan="1">49.23 (8.92)</td><td align="left" colspan="1" rowspan="1">51.74 (10.47)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Hispanic</td><td align="left" colspan="1" rowspan="1">53.44 (10.54)</td><td align="left" colspan="1" rowspan="1">47.98 (10.65)</td><td align="left" colspan="1" rowspan="1">49.31 (11.58)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.51</td><td align="left" colspan="1" rowspan="1">0.09</td><td align="left" colspan="1" rowspan="1">0.01</td></tr><tr><td align="left" colspan="4" rowspan="1">Preferred language</td></tr><tr><td align="left" colspan="1" rowspan="1"> English</td><td align="left" colspan="1" rowspan="1">53.07 (9.27)</td><td align="left" colspan="1" rowspan="1">48.97 (9.28)</td><td align="left" colspan="1" rowspan="1">51.27 (10.96)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Spanish</td><td align="left" colspan="1" rowspan="1">53.47 (11.14)</td><td align="left" colspan="1" rowspan="1">47.63 (11.05)</td><td align="left" colspan="1" rowspan="1">48.27 (11.06)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.76</td><td align="left" colspan="1" rowspan="1">0.05</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.01</td></tr><tr><td align="left" colspan="4" rowspan="1">Marital status</td></tr><tr><td align="left" colspan="1" rowspan="1"> Married</td><td align="left" colspan="1" rowspan="1">53 (9.45)</td><td align="left" colspan="1" rowspan="1">48.52 (9.53)</td><td align="left" colspan="1" rowspan="1">50.63 (10.89)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Divorced</td><td align="left" colspan="1" rowspan="1">53.59 (11.21)</td><td align="left" colspan="1" rowspan="1">47.98 (10.76)</td><td align="left" colspan="1" rowspan="1">49.92 (11.63)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Single</td><td align="left" colspan="1" rowspan="1">54 (9.69)</td><td align="left" colspan="1" rowspan="1">49.60 (9.52)</td><td align="left" colspan="1" rowspan="1">50.7 (11.19)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Widowed</td><td align="left" colspan="1" rowspan="1">51.85 (10.59)</td><td align="left" colspan="1" rowspan="1">48.61 (10.89)</td><td align="left" colspan="1" rowspan="1">49.61 (11.44)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.66</td><td align="left" colspan="1" rowspan="1">0.77</td><td align="left" colspan="1" rowspan="1">0.89</td></tr><tr><td align="left" colspan="4" rowspan="1">Insurance</td></tr><tr><td align="left" colspan="1" rowspan="1"> Private</td><td align="left" colspan="1" rowspan="1">53.31 (10.10)</td><td align="left" colspan="1" rowspan="1">48.36 (9.99)</td><td align="left" colspan="1" rowspan="1">50.01 (11.30)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Government</td><td align="left" colspan="1" rowspan="1">53.28 (8.96)</td><td align="left" colspan="1" rowspan="1">49.9 (9.07)</td><td align="left" colspan="1" rowspan="1">52.43 (10.20)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Self-pay</td><td align="left" colspan="1" rowspan="1">49.6 (9.23)</td><td align="left" colspan="1" rowspan="1">44.73 (9.81)</td><td align="left" colspan="1" rowspan="1">47.05 (9.23)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.27</td><td align="left" colspan="1" rowspan="1">0.05</td><td align="left" colspan="1" rowspan="1">0.08</td></tr><tr><td align="left" colspan="4" rowspan="1">Disease</td></tr><tr><td align="left" colspan="1" rowspan="1"> Cervix</td><td align="left" colspan="1" rowspan="1">53.25 (10.10)</td><td align="left" colspan="1" rowspan="1">48.29 (9.29)</td><td align="left" colspan="1" rowspan="1">49.98 (10.53)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Uterine</td><td align="left" colspan="1" rowspan="1">52.41 (10.04)</td><td align="left" colspan="1" rowspan="1">48.21 (9.63)</td><td align="left" colspan="1" rowspan="1">49.22 (10.70)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ovary</td><td align="left" colspan="1" rowspan="1">53.44 (9.63)</td><td align="left" colspan="1" rowspan="1">48.97 (10.13)</td><td align="left" colspan="1" rowspan="1">51.29 (10.70)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Other</td><td align="left" colspan="1" rowspan="1">55.12 (9.21)</td><td align="left" colspan="1" rowspan="1">49.10 (10.63)</td><td align="left" colspan="1" rowspan="1">52.95 (13.85)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.26</td><td align="left" colspan="1" rowspan="1">0.81</td><td align="left" colspan="1" rowspan="1">0.20</td></tr><tr><td align="left" colspan="4" rowspan="1">Recurrence</td></tr><tr><td align="left" colspan="1" rowspan="1"> No</td><td align="left" colspan="1" rowspan="1">51.61 (10.00)</td><td align="left" colspan="1" rowspan="1">46.78 (9.53)</td><td align="left" colspan="1" rowspan="1">48.18 (11.03)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Yes</td><td align="left" colspan="1" rowspan="1">54.23 (9.59)</td><td align="left" colspan="1" rowspan="1">49.91 (9.86)</td><td align="left" colspan="1" rowspan="1">51.77 (10.92)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.006</td><td align="left" colspan="1" rowspan="1">0.001</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table></table-wrap><table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p>Patient characteristics relative to physical functioning, quality of life (QOL), and pain scores</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variable</th><th align="left" colspan="1" rowspan="1">Physical functioning (mean, SD)</th><th align="left" colspan="1" rowspan="1">QOL score (mean, SD)</th><th align="left" colspan="1" rowspan="1">Pain (mean, SD)</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">Race</td></tr><tr><td align="left" colspan="1" rowspan="1"> White</td><td align="left" colspan="1" rowspan="1">45.13 (11.38)</td><td align="left" colspan="1" rowspan="1">19.05 (5.83)</td><td align="left" colspan="1" rowspan="1">52.35 (10.81)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Black</td><td align="left" colspan="1" rowspan="1">45.17 (9.86)</td><td align="left" colspan="1" rowspan="1">18.86 (5.51)</td><td align="left" colspan="1" rowspan="1">52.40 (9.36)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Other</td><td align="left" colspan="1" rowspan="1">46.67 (11.36)</td><td align="left" colspan="1" rowspan="1">19.38 (6.05)</td><td align="left" colspan="1" rowspan="1">52.62 (10.92)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.66</td><td align="left" colspan="1" rowspan="1">0.82</td><td align="left" colspan="1" rowspan="1">0.99</td></tr><tr><td align="left" colspan="4" rowspan="1">Ethnicity</td></tr><tr><td align="left" colspan="1" rowspan="1"> Non-Hispanic</td><td align="left" colspan="1" rowspan="1">44.97 (10.29)</td><td align="left" colspan="1" rowspan="1">18.92 (5.52)</td><td align="left" colspan="1" rowspan="1">51.95 (10.26)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Hispanic</td><td align="left" colspan="1" rowspan="1">45.31 (12.02)</td><td align="left" colspan="1" rowspan="1">19.07 (6.01)</td><td align="left" colspan="1" rowspan="1">52.79 (10.97)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.87</td><td align="left" colspan="1" rowspan="1">0.59</td><td align="left" colspan="1" rowspan="1">0.42</td></tr><tr><td align="left" colspan="4" rowspan="1">Preferred language</td></tr><tr><td align="left" colspan="1" rowspan="1"> English</td><td align="left" colspan="1" rowspan="1">45.41 (10.56)</td><td align="left" colspan="1" rowspan="1">19.02 (5.67)</td><td align="left" colspan="1" rowspan="1">52.17 (10.39)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Spanish</td><td align="left" colspan="1" rowspan="1">44.77 (12.55)</td><td align="left" colspan="1" rowspan="1">19.11 (6.03)</td><td align="left" colspan="1" rowspan="1">52.84 (11.07)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.38</td><td align="left" colspan="1" rowspan="1">0.71</td><td align="left" colspan="1" rowspan="1">0.67</td></tr><tr><td align="left" colspan="4" rowspan="1">Marital status</td></tr><tr><td align="left" colspan="1" rowspan="1"> Married</td><td align="left" colspan="1" rowspan="1">45.04 (10.95)</td><td align="left" colspan="1" rowspan="1">19.16 (5.53)</td><td align="left" colspan="1" rowspan="1">52.21 (10.33)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Divorced</td><td align="left" colspan="1" rowspan="1">45.74 (10.90)</td><td align="left" colspan="1" rowspan="1">19.21 (5.99)</td><td align="left" colspan="1" rowspan="1">51.24 (10.25)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Single</td><td align="left" colspan="1" rowspan="1">45.61 (12.02)</td><td align="left" colspan="1" rowspan="1">18.57 (6.33)</td><td align="left" colspan="1" rowspan="1">53.85 (11.17)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Widowed</td><td align="left" colspan="1" rowspan="1">42.94 (11.55)</td><td align="left" colspan="1" rowspan="1">18.52 (5.89)</td><td align="left" colspan="1" rowspan="1">53.94 (11.71)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.81</td><td align="left" colspan="1" rowspan="1">0.85</td><td align="left" colspan="1" rowspan="1">0.45</td></tr><tr><td align="left" colspan="4" rowspan="1">Insurance</td></tr><tr><td align="left" colspan="1" rowspan="1"> Private</td><td align="left" colspan="1" rowspan="1">46.03 (11.38)</td><td align="left" colspan="1" rowspan="1">19.15 (5.89)</td><td align="left" colspan="1" rowspan="1">52.14 (10.78)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Government</td><td align="left" colspan="1" rowspan="1">41.41 (9.36)</td><td align="left" colspan="1" rowspan="1">18.38 (5.51)</td><td align="left" colspan="1" rowspan="1">53.35 (9.96)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Self-pay</td><td align="left" colspan="1" rowspan="1">49.21 (12.59)</td><td align="left" colspan="1" rowspan="1">20.5 (4.58)</td><td align="left" colspan="1" rowspan="1">50.95 (10.27)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">0.23</td><td align="left" colspan="1" rowspan="1">0.34</td></tr><tr><td align="left" colspan="4" rowspan="1">Disease</td></tr><tr><td align="left" colspan="1" rowspan="1"> Cervix</td><td align="left" colspan="1" rowspan="1">46.11 (11.72)</td><td align="left" colspan="1" rowspan="1">19.35 (5.54)</td><td align="left" colspan="1" rowspan="1">53.39 (10.78)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Uterine</td><td align="left" colspan="1" rowspan="1">45.67 (10.92)</td><td align="left" colspan="1" rowspan="1">19.34 (6.13)</td><td align="left" colspan="1" rowspan="1">51.42 (10.93)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ovary</td><td align="left" colspan="1" rowspan="1">44.72 (10.74)</td><td align="left" colspan="1" rowspan="1">18.64 (5.06)</td><td align="left" colspan="1" rowspan="1">52.97 (9.78)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Other</td><td align="left" colspan="1" rowspan="1">42.95 (12.83)</td><td align="left" colspan="1" rowspan="1">18.52 (6.99)</td><td align="left" colspan="1" rowspan="1">52.28 (11.48)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.35</td><td align="left" colspan="1" rowspan="1">0.31</td><td align="left" colspan="1" rowspan="1">0.25</td></tr><tr><td align="left" colspan="4" rowspan="1">Recurrence</td></tr><tr><td align="left" colspan="1" rowspan="1"> No</td><td align="left" colspan="1" rowspan="1">48.76 (11.30)</td><td align="left" colspan="1" rowspan="1">20.57 (5.51)</td><td align="left" colspan="1" rowspan="1">49.88 (10.53)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Yes</td><td align="left" colspan="1" rowspan="1">42.48 (10.36)</td><td align="left" colspan="1" rowspan="1">17.90 (5.62)</td><td align="left" colspan="1" rowspan="1">54.15 (10.30)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr></tbody></table></table-wrap></p><p id="Par16">There was no difference in the proportion of patients with recurrent disease by ethnicity (non-Hispanic White 62.9% vs Hispanic 63.5%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.88) or primary language (English 64.4% vs Spanish 62.7%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.71). Hispanic patients were significantly younger than non-Hispanic patients (54.6 {SD 12.3} years vs 56.5 {SD 14.0} years, <italic toggle="yes">p</italic>&#8201;=&#8201;0.02), but Spanish-speaking patients were older than English-speaking patients when PROs were reported (61.4 {SD 12.9} years vs 59.1 {SD 13.3} years, <italic toggle="yes">p</italic>&#8201;=&#8201;0.047). There was no difference in age at completion of PROs by ethnicity (non-Hispanics 60.3 {SD 12.9} years vs Hispanic 59.4 {SD 13.4} years, <italic toggle="yes">p</italic>&#8201;=&#8201;0.52). Time since cancer diagnosis at completion of PROs was shorter for Hispanic (non-Hispanic 5.1 {SD 3.1} years vs 3.4 {SD 2.7} years for Hispanic, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) and Spanish-speaking patients (English preferred 4.40 {SD 2.81} years vs 3.82 {SD 3.29} years for Spanish preferred, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001).</p><p id="Par17">PRO severity was then compared among groups (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>). There were no differences in the proportion of patients with high symptom burden for any PRO measures by race, ethnicity, or preferred language. There were also no differences by marital status, insurance coverage, types of disease, or whether the patient had recurred. A higher proportion of current smokers reported worse physical functioning than never/former smokers (13.4% vs 6.5%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.03).
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table&#160;4</label><caption><p>Proportion of patients with high (moderate/severe) responses by PRO measure (number, %)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variable</th><th align="left" colspan="1" rowspan="1">Anxiety</th><th align="left" colspan="1" rowspan="1">Depression</th><th align="left" colspan="1" rowspan="1">Fatigue</th><th align="left" colspan="1" rowspan="1">Physical functioning</th><th align="left" colspan="1" rowspan="1">Pain</th></tr></thead><tbody><tr><td align="left" colspan="6" rowspan="1">Race</td></tr><tr><td align="left" colspan="1" rowspan="1"> White</td><td align="left" colspan="1" rowspan="1">44 (10.6)</td><td align="left" colspan="1" rowspan="1">48 (12.2)</td><td align="left" colspan="1" rowspan="1">17 (4.4)</td><td align="left" colspan="1" rowspan="1">29 (7.4)</td><td align="left" colspan="1" rowspan="1">18 (4.5)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Black</td><td align="left" colspan="1" rowspan="1">10 (11.8)</td><td align="left" colspan="1" rowspan="1">12 (14.5)</td><td align="left" colspan="1" rowspan="1">2 (2.5)</td><td align="left" colspan="1" rowspan="1">7 (8.6)</td><td align="left" colspan="1" rowspan="1">2 (2.5)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Other</td><td align="left" colspan="1" rowspan="1">2 (9.5)</td><td align="left" colspan="1" rowspan="1">3 (15)</td><td align="left" colspan="1" rowspan="1">2 (10.5)</td><td align="left" colspan="1" rowspan="1">3 (15)</td><td align="left" colspan="1" rowspan="1">3 (14.3)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.93</td><td align="left" colspan="1" rowspan="1">0.81</td><td align="left" colspan="1" rowspan="1">0.30</td><td align="left" colspan="1" rowspan="1">0.45</td><td align="left" colspan="1" rowspan="1">0.07</td></tr><tr><td align="left" colspan="6" rowspan="1">Ethnicity</td></tr><tr><td align="left" colspan="1" rowspan="1"> Non-Hispanic</td><td align="left" colspan="1" rowspan="1">22 (9)</td><td align="left" colspan="1" rowspan="1">26 (11.2)</td><td align="left" colspan="1" rowspan="1">12 (5.3)</td><td align="left" colspan="1" rowspan="1">20 (8.8)</td><td align="left" colspan="1" rowspan="1">9 (3.4)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Hispanic</td><td align="left" colspan="1" rowspan="1">34 (12.4)</td><td align="left" colspan="1" rowspan="1">28 (14.6)</td><td align="left" colspan="1" rowspan="1">9 (3.8)</td><td align="left" colspan="1" rowspan="1">19 (7.3)</td><td align="left" colspan="1" rowspan="1">14 (5.4)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.22</td><td align="left" colspan="1" rowspan="1">0.25</td><td align="left" colspan="1" rowspan="1">0.36</td><td align="left" colspan="1" rowspan="1">0.56</td><td align="left" colspan="1" rowspan="1">0.44</td></tr><tr><td align="left" colspan="6" rowspan="1">Preferred language</td></tr><tr><td align="left" colspan="1" rowspan="1"> English</td><td align="left" colspan="1" rowspan="1">35 (9.7)</td><td align="left" colspan="1" rowspan="1">43 (12.6)</td><td align="left" colspan="1" rowspan="1">15 (4.5)</td><td align="left" colspan="1" rowspan="1">30 (8.9)</td><td align="left" colspan="1" rowspan="1">15 (4.3)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Spanish</td><td align="left" colspan="1" rowspan="1">22 (13.1)</td><td align="left" colspan="1" rowspan="1">22 (13.6)</td><td align="left" colspan="1" rowspan="1">7 (4.4)</td><td align="left" colspan="1" rowspan="1">10 (6.2)</td><td align="left" colspan="1" rowspan="1">8 (5.1)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.24</td><td align="left" colspan="1" rowspan="1">0.76</td><td align="left" colspan="1" rowspan="1">0.93</td><td align="left" colspan="1" rowspan="1">0.30</td><td align="left" colspan="1" rowspan="1">0.72</td></tr><tr><td align="left" colspan="6" rowspan="1">Marital status</td></tr><tr><td align="left" colspan="1" rowspan="1"> Married</td><td align="left" colspan="1" rowspan="1">32 (11.2)</td><td align="left" colspan="1" rowspan="1">34 (12.7)</td><td align="left" colspan="1" rowspan="1">13 (5)</td><td align="left" colspan="1" rowspan="1">22 (8.3)</td><td align="left" colspan="1" rowspan="1">12 (4.5)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Divorced</td><td align="left" colspan="1" rowspan="1">5 (5.6)</td><td align="left" colspan="1" rowspan="1">10 (11.8)</td><td align="left" colspan="1" rowspan="1">2 (2.4)</td><td align="left" colspan="1" rowspan="1">5 (5.9)</td><td align="left" colspan="1" rowspan="1">1 (1.2)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Single</td><td align="left" colspan="1" rowspan="1">15 (13.5)</td><td align="left" colspan="1" rowspan="1">17 (15.9)</td><td align="left" colspan="1" rowspan="1">5 (4.8)</td><td align="left" colspan="1" rowspan="1">10 (9.3)</td><td align="left" colspan="1" rowspan="1">8 (7.5)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Widowed</td><td align="left" colspan="1" rowspan="1">3 (8.8)</td><td align="left" colspan="1" rowspan="1">2 (5.9)</td><td align="left" colspan="1" rowspan="1">1 (3.2)</td><td align="left" colspan="1" rowspan="1">3 (9.4)</td><td align="left" colspan="1" rowspan="1">2 (6.1)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.31</td><td align="left" colspan="1" rowspan="1">0.48</td><td align="left" colspan="1" rowspan="1">0.77</td><td align="left" colspan="1" rowspan="1">0.84</td><td align="left" colspan="1" rowspan="1">0.22</td></tr><tr><td align="left" colspan="6" rowspan="1">Insurance</td></tr><tr><td align="left" colspan="1" rowspan="1"> Private</td><td align="left" colspan="1" rowspan="1">43 (10.9)</td><td align="left" colspan="1" rowspan="1">52 (13.9)</td><td align="left" colspan="1" rowspan="1">18 (4.9)</td><td align="left" colspan="1" rowspan="1">25 (6.7)</td><td align="left" colspan="1" rowspan="1">13 (3.4)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Government</td><td align="left" colspan="1" rowspan="1">12 (10.3)</td><td align="left" colspan="1" rowspan="1">13 (11.5)</td><td align="left" colspan="1" rowspan="1">3 (2.7)</td><td align="left" colspan="1" rowspan="1">12 (10.8)</td><td align="left" colspan="1" rowspan="1">9 (8.3)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Self-pay</td><td align="left" colspan="1" rowspan="1">2 (11.1)</td><td align="left" colspan="1" rowspan="1">0 (0)</td><td align="left" colspan="1" rowspan="1">1 (6.3)</td><td align="left" colspan="1" rowspan="1">3 (18.8)</td><td align="left" colspan="1" rowspan="1">1 (6.3)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.98</td><td align="left" colspan="1" rowspan="1">0.24</td><td align="left" colspan="1" rowspan="1">0.57</td><td align="left" colspan="1" rowspan="1">0.08</td><td align="left" colspan="1" rowspan="1">0.09</td></tr><tr><td align="left" colspan="6" rowspan="1">Disease</td></tr><tr><td align="left" colspan="1" rowspan="1"> Cervix</td><td align="left" colspan="1" rowspan="1">9 (10)</td><td align="left" colspan="1" rowspan="1">10 (11.4)</td><td align="left" colspan="1" rowspan="1">3 (3.5)</td><td align="left" colspan="1" rowspan="1">6 (6.7)</td><td align="left" colspan="1" rowspan="1">3 (3.4)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Uterine</td><td align="left" colspan="1" rowspan="1">19 (9.2)</td><td align="left" colspan="1" rowspan="1">29 (14.9)</td><td align="left" colspan="1" rowspan="1">6 (3.2)</td><td align="left" colspan="1" rowspan="1">12 (6.4)</td><td align="left" colspan="1" rowspan="1">7 (3.6)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ovary</td><td align="left" colspan="1" rowspan="1">22 (12.0)</td><td align="left" colspan="1" rowspan="1">20 (11.4)</td><td align="left" colspan="1" rowspan="1">10 (5.7)</td><td align="left" colspan="1" rowspan="1">16 (9)</td><td align="left" colspan="1" rowspan="1">9 (5.1)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Other</td><td align="left" colspan="1" rowspan="1">7 (13.7)</td><td align="left" colspan="1" rowspan="1">6 (13)</td><td align="left" colspan="1" rowspan="1">3 (6.8)</td><td align="left" colspan="1" rowspan="1">6 (13.3)</td><td align="left" colspan="1" rowspan="1">4 (8.5)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.72</td><td align="left" colspan="1" rowspan="1">0.73</td><td align="left" colspan="1" rowspan="1">0.55</td><td align="left" colspan="1" rowspan="1">0.42</td><td align="left" colspan="1" rowspan="1">0.47</td></tr><tr><td align="left" colspan="6" rowspan="1">Smoking</td></tr><tr><td align="left" colspan="1" rowspan="1"> Never/former</td><td align="left" colspan="1" rowspan="1">32 (11)</td><td align="left" colspan="1" rowspan="1">32 (11.7)</td><td align="left" colspan="1" rowspan="1">14 (5.2)</td><td align="left" colspan="1" rowspan="1">18 (6.5)</td><td align="left" colspan="1" rowspan="1">13 (4.7)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Current</td><td align="left" colspan="1" rowspan="1">13 (12.3)</td><td align="left" colspan="1" rowspan="1">15 (14.7)</td><td align="left" colspan="1" rowspan="1">3 (3.1)</td><td align="left" colspan="1" rowspan="1">13 (13.4)</td><td align="left" colspan="1" rowspan="1">3 (3)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.73</td><td align="left" colspan="1" rowspan="1">0.43</td><td align="left" colspan="1" rowspan="1">0.41</td><td align="left" colspan="1" rowspan="1">0.03</td><td align="left" colspan="1" rowspan="1">0.45</td></tr><tr><td align="left" colspan="6" rowspan="1">Recurrence</td></tr><tr><td align="left" colspan="1" rowspan="1"> No</td><td align="left" colspan="1" rowspan="1">18 (10.1)</td><td align="left" colspan="1" rowspan="1">21 (12.6)</td><td align="left" colspan="1" rowspan="1">8 (4.9)</td><td align="left" colspan="1" rowspan="1">11 (6.6)</td><td align="left" colspan="1" rowspan="1">6 (3.5)</td></tr><tr><td align="left" colspan="1" rowspan="1"> Yes</td><td align="left" colspan="1" rowspan="1">35 (11.3)</td><td align="left" colspan="1" rowspan="1">41 (13.9)</td><td align="left" colspan="1" rowspan="1">13 (4.5)</td><td align="left" colspan="1" rowspan="1">7 (8.6)</td><td align="left" colspan="1" rowspan="1">15 (5.8)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.68</td><td align="left" colspan="1" rowspan="1">0.69</td><td align="left" colspan="1" rowspan="1">0.83</td><td align="left" colspan="1" rowspan="1">0.39</td><td align="left" colspan="1" rowspan="1">0.43</td></tr></tbody></table></table-wrap></p><p id="Par18">Overall QOL scores were significantly lower in patients who had high symptom severity for anxiety (<italic toggle="yes">p</italic>&#8201;=&#8201;0.04) and physical functioning (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01) (Table&#160;<xref rid="Tab5" ref-type="table">5</xref>). There was no association between overall QOL scores and reported severity for depression, fatigue, and pain. Overall QOL scores did not vary by race (<italic toggle="yes">p</italic>&#8201;=&#8201;0.82), ethnicity (<italic toggle="yes">p</italic>&#8201;=&#8201;0.59), or preferred language (<italic toggle="yes">p</italic>&#8201;=&#8201;0.71).
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table&#160;5</label><caption><p>Quality of life scores as related to severity of PROs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">PRO measure</th><th align="left" colspan="1" rowspan="1">Mean T-score (SD): low severity</th><th align="left" colspan="1" rowspan="1">Mean T-score (SD): high severity</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Anxiety</td><td align="left" colspan="1" rowspan="1">19.19 (5.73)</td><td align="left" colspan="1" rowspan="1">17.39 (5.63)</td><td align="left" colspan="1" rowspan="1">0.04</td></tr><tr><td align="left" colspan="1" rowspan="1">Depression</td><td align="left" colspan="1" rowspan="1">18.95 (5.79)</td><td align="left" colspan="1" rowspan="1">19 (5.16)</td><td align="left" colspan="1" rowspan="1">0.99</td></tr><tr><td align="left" colspan="1" rowspan="1">Fatigue</td><td align="left" colspan="1" rowspan="1">19.10 (5.66)</td><td align="left" colspan="1" rowspan="1">17.89 (5.36)</td><td align="left" colspan="1" rowspan="1">0.31</td></tr><tr><td align="left" colspan="1" rowspan="1">Physical functioning</td><td align="left" colspan="1" rowspan="1">19.25 (5.72)</td><td align="left" colspan="1" rowspan="1">17.02 (4.81)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">Pain</td><td align="left" colspan="1" rowspan="1">18.99 (5.76)</td><td align="left" colspan="1" rowspan="1">18.93 (5.89)</td><td align="left" colspan="1" rowspan="1">0.93</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec7"><title>Discussion</title><p id="Par19">Prior studies have reported that racial and ethnic minority patients with cancer have had higher rates of depression and anxiety and overall worse QOL [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR20">20</xref>]. Our cohort, in contrast, demonstrated no differences in QOL or severity of PROMIS scores by race, ethnicity, or preferred language, disproving our primary hypothesis.</p><p id="Par20">QOL scores were significantly lower in patients who had high symptom severity for anxiety and physical functioning. This is consistent with previously reported data which demonstrated that frailty and poor physical function are associated with worse QOL outcomes for cancer survivors in general [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Among gynecologic cancer survivors specifically, a high prevalence of anxiety has also been reported [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], with younger cancer survivors and those with poor physical health experiencing relatively higher levels of anxiety [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Certain subsets of gynecologic cancer survivors are at further increased risk for poor physical functioning, including smokers [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], endometrial cancer survivors with obesity [<xref ref-type="bibr" rid="CR34">34</xref>], and patients who have lower extremity edema due to radical surgery and/or lymph node dissection [<xref ref-type="bibr" rid="CR35">35</xref>]. Patients in these at-risk groups may benefit from targeted interventions aimed at improving physical functioning, including exercise an-d lifestyle interventions, which have been noted to improve both mental health and physical functioning in patients with cancer [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par21">We also observed that patients who were current smokers had worse overall QOL scores relative to never or former smokers. Patients with cancer who smoke experience more pain [<xref ref-type="bibr" rid="CR37">37</xref>], higher cancer-related morbidity [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], and greater treatment-related toxicity, especially when receiving radiation [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. All of these factors may contribute to frailty and worse physical function. For all cancer types, sustained smoking cessation is associated with lower depression, fatigue, and pain scores over time [<xref ref-type="bibr" rid="CR39">39</xref>], and there is an inverse relationship between pain severity and years since quitting for former smokers [<xref ref-type="bibr" rid="CR37">37</xref>]. Support for smoking cessation should be an essential part of comprehensive cancer care for gynecologic cancer survivors, particularly among cervical cancer survivors, who have a high prevalence of smoking and significant treatment-related complications when smoking persists during treatment [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p id="Par22">Significant differences in the raw PROMIS scores were noted across groups, including lower mean fatigue scores for Hispanic- and Spanish-speaking patients and lower mean depression scores for Spanish-speaking patients. While we are unable to interpret the clinical relevance of these small, but statistically significant variations, these trends are intriguing, and consideration should be given to why these observations were made. One lens through which to evaluate these findings could be the &#8220;Hispanic Paradox,&#8221; or the observation that Hispanic patients often have equal or better health outcomes compared to non-Hispanic counterparts despite known disparities in access to care [<xref ref-type="bibr" rid="CR40">40</xref>]. Many cultural and socioeconomic factors have been posited to contribute to the Hispanic paradox, including the &#8220;healthy immigrant effect,&#8221; which describes the phenomenon of better health outcomes among patients who recently immigrated [<xref ref-type="bibr" rid="CR40">40</xref>]. This phenomenon is particularly salient for the population served at our institution, as 54% of the population of Miami-Dade County was foreign-born in 2023 [<xref ref-type="bibr" rid="CR41">41</xref>]. Other cultural and institutional factors, such as provider diversity and a high proportion of Spanish-speaking providers, may account for at least part of the better scores measured in this cohort. Provider-patient ethnic and language concordance in cancer care have been previously associated with improved patient satisfaction, mental health, and medical understanding [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR44">44</xref>]. These factors, however, are not well studied in the context of QOL for patients with gynecologic cancer.</p><p id="Par23">There are several identified weaknesses in this study. It was conducted at a single, private institution. This is a population of almost entirely insured patients receiving care at a high-volume tertiary care center. As such, findings in this population may not be generalizable to uninsured patients in more resource-limited settings. This was also a heterogeneous population, including patients with multiple gynecologic cancer types, which will likely affect results. Our findings were not stratified by cancer type, treatment goals (curative versus palliative), or stage at diagnosis. The exclusion of these data points limits a more granular assessment of the patient experience. Capturing these data is an essential consideration for future investigations when a larger sample size is available and robust multivariable analyses more feasible. Our center has a large Haitian population with many patients who prefer Haitian Creole. These patients were unable to be included in this study as the instruments used have not been validated in Haitian Creole. As such, this study cannot give insight into health-related quality of life in this group which contributes significantly to the Black population in our region. These surveys were offered electronically through a web browser or the Epic MyChart patient portal. This may limit accessibility to patients with low literacy or low familiarity, comfort, or access to these platforms. Finally, we did not evaluate interventions performed before or after these assessments. MWC responses, which are visible immediately to the clinical care team, may prompt interventions (such as referrals to social work, nutrition, and physical therapy) that impact the trajectory of future responses. Similarly, prior supportive interventions which may impact responses were not assessed but could be impacting patient quality of life and therefore measured responses.</p><p id="Par24">Despite these weaknesses, however, to our knowledge, this is the largest cohort of Hispanic and Spanish-speaking patients in any published prospective study of PROs for patients with gynecologic cancer. Racial and ethnic minorities made up over half of the cohort of this study. This is also the most extensive study of this kind to offer PRO surveys in both English and Spanish, and thus the impact of language barriers on data collection was significantly reduced. We postulate that this significant diversity is likely what accounts for the lack of differences in measured PRO severity across all racial and ethnic groups. With such a large population of immigrants, in a city where multiple languages are commonly spoken, and with multiple ethnicities and nativities represented&#8212;not just in the general population but also among the physicians and staff&#8212;the cancer experience for our patients is likely unique. Our institutional cohort continues to expand, and it is anticipated that future, more granular PRO and QOL data in our gynecologic cancer subpopulations, as well as our racial and ethnic minority groups, will provide clearer evidence about the impact of patient ancestry or sociocultural background on these measures.</p></sec><sec id="Sec8"><title>Conclusions</title><p id="Par25"> In a large cohort of diverse gynecologic cancer survivors, race, ethnicity, and preferred language were not associated with symptom severity for any PROs or with overall QOL scores. Higher symptom severity for anxiety and physical function were associated with worse overall QOL, and current smokers were more likely to report worse physical function. Our evaluation of raw PRO scores noted a trend towards lower mean depression, anxiety, and fatigue scores for Hispanic and Spanish-speaking patients. This warrants further investigation in a larger population to determine if such trends translate into significant patient impact during cancer treatment and beyond. Supportive programs, such as those aimed at smoking cessation, routine screening for anxiety and depression, and interventions to improve physical function, are possible means of improving QOL and reducing symptom burden for gynecologic cancer survivors. Such programs should acknowledge how the intersectionality of ethnicity may impact the patient experience and further quantify best practices for the diverse populations of women with these diseases.</p></sec><sec id="Sec9" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="520_2024_8968_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary file1 (DOCX 20 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="520_2024_8968_MOESM2_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary file2 (DOCX 19 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contribution</title><p>Study Conception and Design: C.G., A.S., M.S. Data Collection: C.G., A.N., V.S., F.P., M.S. Analyses and Interpretation of Results: C.G., A.S., A.N., V.S., J.M., S.G., C.C., T.C., F.P., M.S. Draft Manuscript and Table preparation: C.G., F.P., M.S. All authors reviewed and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The study was funded in part by grant P30 CA240139 from the National Cancer Institute.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par26">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moss</surname><given-names>HA</given-names></name><name name-style="western"><surname>Havrilesky</surname><given-names>LJ</given-names></name></person-group><article-title>The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care</article-title><source>Gynecol Oncol</source><year>2018</year><volume>148</volume><issue>1</issue><fpage>12</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2017.11.011</pub-id><pub-id pub-id-type="pmid">29174565</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Moss HA, Havrilesky LJ (2018) The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care. Gynecol Oncol 148(1):12&#8211;18. 10.1016/j.ygyno.2017.11.011<pub-id pub-id-type="pmid">29174565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2017.11.011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basch</surname><given-names>E</given-names></name><name name-style="western"><surname>Deal</surname><given-names>AM</given-names></name><name name-style="western"><surname>Dueck</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment</article-title><source>JAMA</source><year>2017</year><volume>318</volume><issue>2</issue><fpage>197</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1001/jama.2017.7156</pub-id><pub-id pub-id-type="pmid">28586821</pub-id><pub-id pub-id-type="pmcid">PMC5817466</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Basch E, Deal AM, Dueck AC et al (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Jama 318(2):197&#8211;98. 10.1001/jama.2017.7156<pub-id pub-id-type="pmid">28586821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2017.7156</pub-id><pub-id pub-id-type="pmcid">PMC5817466</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basch</surname><given-names>E</given-names></name><name name-style="western"><surname>Deal</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kris</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial</article-title><source>J Clin Oncol</source><year>2016</year><volume>34</volume><issue>6</issue><fpage>557</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1200/jco.2015.63.0830</pub-id><pub-id pub-id-type="pmid">26644527</pub-id><pub-id pub-id-type="pmcid">PMC4872028</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Basch E, Deal AM, Kris MG et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557&#8211;65. 10.1200/jco.2015.63.0830<pub-id pub-id-type="pmid">26644527</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2015.63.0830</pub-id><pub-id pub-id-type="pmcid">PMC4872028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knobf</surname><given-names>MT</given-names></name><name name-style="western"><surname>Ferrucci</surname><given-names>LM</given-names></name><name name-style="western"><surname>Cartmel</surname><given-names>B</given-names></name><etal/></person-group><article-title>Needs assessment of cancer survivors in Connecticut</article-title><source>J Cancer Surviv</source><year>2012</year><volume>6</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s11764-011-0198-2</pub-id><pub-id pub-id-type="pmid">21984194</pub-id><pub-id pub-id-type="pmcid">PMC3274636</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Knobf MT, Ferrucci LM, Cartmel B et al (2012) Needs assessment of cancer survivors in Connecticut. J Cancer Surviv 6(1):1&#8211;10. 10.1007/s11764-011-0198-2<pub-id pub-id-type="pmid">21984194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11764-011-0198-2</pub-id><pub-id pub-id-type="pmcid">PMC3274636</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moadel</surname><given-names>AB</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>C</given-names></name><name name-style="western"><surname>Dutcher</surname><given-names>J</given-names></name></person-group><article-title>Psychosocial needs assessment among an underserved, ethnically diverse cancer patient population</article-title><source>Cancer</source><year>2007</year><volume>109</volume><issue>2 Suppl</issue><fpage>446</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1002/cncr.22357</pub-id><pub-id pub-id-type="pmid">17123273</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Moadel AB, Morgan C, Dutcher J (2007) Psychosocial needs assessment among an underserved, ethnically diverse cancer patient population. Cancer 109(2 Suppl):446&#8211;54. 10.1002/cncr.22357<pub-id pub-id-type="pmid">17123273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.22357</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Philp</surname><given-names>L</given-names></name><name name-style="western"><surname>Alimena</surname><given-names>S</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Black and Hispanic women have less support during cancer evaluation and treatment: results from a prospective patient reported outcomes program in gynecologic malignancy</article-title><source>Int J Gynecol Cancer</source><year>2023</year><volume>33</volume><issue>5</issue><fpage>770</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1136/ijgc-2022-004113</pub-id><pub-id pub-id-type="pmid">36639193</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Philp L, Alimena S, Sullivan M et al (2023) Black and Hispanic women have less support during cancer evaluation and treatment: results from a prospective patient reported outcomes program in gynecologic malignancy. Int J Gynecol Cancer 33(5):770&#8211;77. 10.1136/ijgc-2022-004113<pub-id pub-id-type="pmid">36639193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/ijgc-2022-004113</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penedo</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Medina</surname><given-names>HN</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>PI</given-names></name><etal/></person-group><article-title>Implementation and feasibility of an electronic health record-integrated patient-reported outcomes symptom and needs monitoring pilot in ambulatory oncology</article-title><source>JCO Oncol Pract</source><year>2022</year><volume>18</volume><issue>7</issue><fpage>e1100</fpage><lpage>e13</lpage><pub-id pub-id-type="doi">10.1200/op.21.00706</pub-id><pub-id pub-id-type="pmid">35290096</pub-id><pub-id pub-id-type="pmcid">PMC9287298</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Penedo FJ, Medina HN, Moreno PI et al (2022) Implementation and feasibility of an electronic health record-integrated patient-reported outcomes symptom and needs monitoring pilot in ambulatory oncology. JCO Oncol Pract 18(7):e1100&#8211;e13. 10.1200/op.21.00706<pub-id pub-id-type="pmid">35290096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/OP.21.00706</pub-id><pub-id pub-id-type="pmcid">PMC9287298</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Jones N, Marks R, Ramirez R, Rios-Vargas M (2020) Census illuminates racial and ethnic composition of the country. US Census Bureau, August 12, 2021.&#160; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.census.gov/library/stories/2021/08/improved-race-ethnicity-measures-reveal-united-states-populationmuch-more-multiracial.html">https://www.census.gov/library/stories/2021/08/improved-race-ethnicity-measures-reveal-united-states-populationmuch-more-multiracial.html</ext-link>.&#160;Accessed 21 July 2024</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>CM</given-names></name><name name-style="western"><surname>Wentzensen</surname><given-names>N</given-names></name><name name-style="western"><surname>Castle</surname><given-names>PE</given-names></name><etal/></person-group><article-title>Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype</article-title><source>J Clin Oncol</source><year>2023</year><volume>41</volume><issue>5</issue><fpage>1059</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1200/jco.22.01424</pub-id><pub-id pub-id-type="pmid">36455190</pub-id><pub-id pub-id-type="pmcid">PMC9928618</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Cohen CM, Wentzensen N, Castle PE et al (2023) Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype. J Clin Oncol 41(5):1059&#8211;68. 10.1200/jco.22.01424<pub-id pub-id-type="pmid">36455190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.22.01424</pub-id><pub-id pub-id-type="pmcid">PMC9928618</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goel</surname><given-names>MS</given-names></name><name name-style="western"><surname>Wee</surname><given-names>CC</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>EP</given-names></name><name name-style="western"><surname>Davis</surname><given-names>RB</given-names></name><name name-style="western"><surname>Ngo-Metzger</surname><given-names>Q</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>RS</given-names></name></person-group><article-title>Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care</article-title><source>J Gen Intern Med</source><year>2003</year><volume>18</volume><issue>12</issue><fpage>1028</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/j.1525-1497.2003.20807.x</pub-id><pub-id pub-id-type="pmid">14687262</pub-id><pub-id pub-id-type="pmcid">PMC1494963</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS (2003) Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med 18(12):1028&#8211;35. 10.1111/j.1525-1497.2003.20807.x<pub-id pub-id-type="pmid">14687262</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1525-1497.2003.20807.x</pub-id><pub-id pub-id-type="pmcid">PMC1494963</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>FW</given-names></name><name name-style="western"><surname>Randall</surname><given-names>LM</given-names></name><name name-style="western"><surname>Tewari</surname><given-names>KS</given-names></name><name name-style="western"><surname>Bristow</surname><given-names>RE</given-names></name></person-group><article-title>Racial disparities and patterns of ovarian cancer surgical care in California</article-title><source>Gynecol Oncol</source><year>2014</year><volume>132</volume><issue>1</issue><fpage>221</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2013.08.035</pub-id><pub-id pub-id-type="pmid">24016407</pub-id><pub-id pub-id-type="pmcid">PMC4423747</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Liu FW, Randall LM, Tewari KS, Bristow RE (2014) Racial disparities and patterns of ovarian cancer surgical care in California. Gynecol Oncol 132(1):221&#8211;6. 10.1016/j.ygyno.2013.08.035<pub-id pub-id-type="pmid">24016407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2013.08.035</pub-id><pub-id pub-id-type="pmcid">PMC4423747</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>KD</given-names></name><name name-style="western"><surname>Nogueira</surname><given-names>L</given-names></name><name name-style="western"><surname>Devasia</surname><given-names>T</given-names></name><etal/></person-group><article-title>2022 Cancer treatment and survivorship statistics</article-title><source>CA Cancer J Clin</source><year>2022</year><volume>72</volume><issue>5</issue><fpage>409</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.3322/caac.21731</pub-id><pub-id pub-id-type="pmid">35736631</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Miller KD, Nogueira L, Devasia T et al (2022) 2022 Cancer treatment and survivorship statistics. CA Cancer J Clin 72(5):409&#8211;36. 10.3322/caac.21731<pub-id pub-id-type="pmid">35736631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21731</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schlumbrecht</surname><given-names>M</given-names></name><name name-style="western"><surname>Wright</surname><given-names>K</given-names></name><name name-style="western"><surname>George</surname><given-names>S</given-names></name></person-group><article-title>Unique considerations in early detection, risk, and awareness of endometrial cancer in Black women</article-title><source>Cancer Control</source><year>2023</year><volume>30</volume><fpage>10732748231202952</fpage><pub-id pub-id-type="doi">10.1177/10732748231202952</pub-id><pub-id pub-id-type="pmid">37732413</pub-id><pub-id pub-id-type="pmcid">PMC10515581</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Schlumbrecht M, Wright K, George S (2023) Unique considerations in early detection, risk, and awareness of endometrial cancer in Black women. Cancer Control 30:10732748231202952. 10.1177/10732748231202952<pub-id pub-id-type="pmid">37732413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/10732748231202952</pub-id><pub-id pub-id-type="pmcid">PMC10515581</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>VE</given-names></name><name name-style="western"><surname>LeBr&#243;n</surname><given-names>AMW</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J</given-names></name><name name-style="western"><surname>Bristow</surname><given-names>RE</given-names></name></person-group><article-title>Racial-ethnic and socioeconomic disparities in guideline-adherent treatment for endometrial cancer</article-title><source>Obstet Gynecol</source><year>2021</year><volume>138</volume><issue>1</issue><fpage>21</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1097/aog.0000000000004424</pub-id><pub-id pub-id-type="pmid">34259460</pub-id><pub-id pub-id-type="pmcid">PMC10403994</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Rodriguez VE, LeBr&#243;n AMW, Chang J, Bristow RE (2021) Racial-ethnic and socioeconomic disparities in guideline-adherent treatment for endometrial cancer. Obstet Gynecol 138(1):21&#8211;31. 10.1097/aog.0000000000004424<pub-id pub-id-type="pmid">34259460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0000000000004424</pub-id><pub-id pub-id-type="pmcid">PMC10403994</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albright</surname><given-names>BB</given-names></name><name name-style="western"><surname>Nasioudis</surname><given-names>D</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>ME</given-names></name><name name-style="western"><surname>Latif</surname><given-names>NA</given-names></name><name name-style="western"><surname>Ko</surname><given-names>EM</given-names></name><name name-style="western"><surname>Haggerty</surname><given-names>AF</given-names></name></person-group><article-title>Perioperative outcomes and disparities in utilization of sentinel lymph node biopsy in minimally invasive staging of endometrial cancer</article-title><source>Gynecol Oncol</source><year>2020</year><volume>159</volume><issue>3</issue><fpage>758</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2020.09.032</pub-id><pub-id pub-id-type="pmid">32981697</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Albright BB, Nasioudis D, Byrne ME, Latif NA, Ko EM, Haggerty AF (2020) Perioperative outcomes and disparities in utilization of sentinel lymph node biopsy in minimally invasive staging of endometrial cancer. Gynecol Oncol 159(3):758&#8211;66. 10.1016/j.ygyno.2020.09.032<pub-id pub-id-type="pmid">32981697</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2020.09.032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahdi</surname><given-names>H</given-names></name><name name-style="western"><surname>Hou</surname><given-names>H</given-names></name><name name-style="western"><surname>Kowk</surname><given-names>LL</given-names></name><name name-style="western"><surname>Moslemi-Kebria</surname><given-names>M</given-names></name><name name-style="western"><surname>Michener</surname><given-names>C</given-names></name></person-group><article-title>Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women</article-title><source>Gynecol Oncol</source><year>2014</year><volume>133</volume><issue>3</issue><fpage>512</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2014.03.562</pub-id><pub-id pub-id-type="pmid">24674830</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Mahdi H, Hou H, Kowk LL, Moslemi-Kebria M, Michener C (2014) Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women. Gynecol Oncol 133(3):512&#8211;7. 10.1016/j.ygyno.2014.03.562<pub-id pub-id-type="pmid">24674830</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2014.03.562</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>JS</given-names></name><name name-style="western"><surname>He</surname><given-names>W</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>R</given-names></name><etal/></person-group><article-title>Disparities in treatment and survival among elderly ovarian cancer patients</article-title><source>Gynecol Oncol</source><year>2018</year><volume>151</volume><issue>2</issue><fpage>269</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2018.08.041</pub-id><pub-id pub-id-type="pmid">30253875</pub-id><pub-id pub-id-type="pmcid">PMC6294439</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Taylor JS, He W, Harrison R et al (2018) Disparities in treatment and survival among elderly ovarian cancer patients. Gynecol Oncol 151(2):269&#8211;74. 10.1016/j.ygyno.2018.08.041<pub-id pub-id-type="pmid">30253875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2018.08.041</pub-id><pub-id pub-id-type="pmcid">PMC6294439</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayanian</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Zaslavsky</surname><given-names>AM</given-names></name><name name-style="western"><surname>Guadagnoli</surname><given-names>E</given-names></name><etal/></person-group><article-title>Patients&#8217; perceptions of quality of care for colorectal cancer by race, ethnicity, and language</article-title><source>J Clin Oncol</source><year>2005</year><volume>23</volume><issue>27</issue><fpage>6576</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1200/jco.2005.06.102</pub-id><pub-id pub-id-type="pmid">16116149</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Ayanian JZ, Zaslavsky AM, Guadagnoli E et al (2005) Patients&#8217; perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol 23(27):6576&#8211;86. 10.1200/jco.2005.06.102<pub-id pub-id-type="pmid">16116149</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2005.06.102</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luckett</surname><given-names>T</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>D</given-names></name><name name-style="western"><surname>Butow</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis</article-title><source>Lancet Oncol</source><year>2011</year><volume>12</volume><issue>13</issue><fpage>1240</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/s1470-2045(11)70212-1</pub-id><pub-id pub-id-type="pmid">21996168</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Luckett T, Goldstein D, Butow PN et al (2011) Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis. Lancet Oncol 12(13):1240&#8211;8. 10.1016/s1470-2045(11)70212-1<pub-id pub-id-type="pmid">21996168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1470-2045(11)70212-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yanez</surname><given-names>B</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>EH</given-names></name><name name-style="western"><surname>Stanton</surname><given-names>AL</given-names></name></person-group><article-title>Quality of life among Latina breast cancer patients: a systematic review of the literature</article-title><source>J Cancer Surviv</source><year>2011</year><volume>5</volume><issue>2</issue><fpage>191</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1007/s11764-011-0171-0</pub-id><pub-id pub-id-type="pmid">21274649</pub-id><pub-id pub-id-type="pmcid">PMC3096762</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Yanez B, Thompson EH, Stanton AL (2011) Quality of life among Latina breast cancer patients: a systematic review of the literature. J Cancer Surviv 5(2):191&#8211;207. 10.1007/s11764-011-0171-0<pub-id pub-id-type="pmid">21274649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11764-011-0171-0</pub-id><pub-id pub-id-type="pmcid">PMC3096762</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rose</surname><given-names>M</given-names></name><name name-style="western"><surname>Bjorner</surname><given-names>J</given-names></name><name name-style="western"><surname>Becker</surname><given-names>J</given-names></name><name name-style="western"><surname>Fries</surname><given-names>J</given-names></name><name name-style="western"><surname>Ware</surname><given-names>J</given-names></name></person-group><article-title>Evaluation of a preliminary physical function item bank supported the expected advantage of the Patient-Reported Outcomes Measurement Information System (PROMIS)</article-title><source>J Clin Epidemiol</source><year>2008</year><volume>61</volume><issue>1</issue><fpage>17</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2006.06.025</pub-id><pub-id pub-id-type="pmid">18083459</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Rose M, Bjorner J, Becker J, Fries J, Ware J (2008) Evaluation of a preliminary physical function item bank supported the expected advantage of the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol 61(1):17&#8211;33<pub-id pub-id-type="pmid">18083459</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2006.06.025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pilkonis</surname><given-names>P</given-names></name><name name-style="western"><surname>Choi</surname><given-names>S</given-names></name><name name-style="western"><surname>Reise</surname><given-names>S</given-names></name><name name-style="western"><surname>Stover</surname><given-names>A</given-names></name><name name-style="western"><surname>Riley</surname><given-names>W</given-names></name><name name-style="western"><surname>Cella</surname><given-names>D</given-names></name></person-group><article-title>Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS): depression, anxiety, and anger</article-title><source>Assessment</source><year>2011</year><volume>18</volume><issue>3</issue><fpage>263</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1177/1073191111411667</pub-id><pub-id pub-id-type="pmid">21697139</pub-id><pub-id pub-id-type="pmcid">PMC3153635</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Pilkonis P, Choi S, Reise S, Stover A, Riley W, Cella D (2011) Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS): depression, anxiety, and anger. Assessment 18(3):263&#8211;283<pub-id pub-id-type="pmid">21697139</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1073191111411667</pub-id><pub-id pub-id-type="pmcid">PMC3153635</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amtmann</surname><given-names>D</given-names></name><name name-style="western"><surname>Cook</surname><given-names>K</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Development of a PROMIS item back to measure pain interference</article-title><source>Pain</source><year>2010</year><volume>150</volume><issue>1</issue><fpage>183</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2010.04.025</pub-id><pub-id pub-id-type="pmid">20554116</pub-id><pub-id pub-id-type="pmcid">PMC2916053</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Amtmann D, Cook K, Jensen M et al (2010) Development of a PROMIS item back to measure pain interference. Pain 150(1):183&#8211;282<pub-id pub-id-type="pmid">20554116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pain.2010.04.025</pub-id><pub-id pub-id-type="pmcid">PMC2916053</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>J</given-names></name><name name-style="western"><surname>Cella</surname><given-names>D</given-names></name><name name-style="western"><surname>Choi</surname><given-names>S</given-names></name><etal/></person-group><article-title>How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMISE fatigue item bank example</article-title><source>Arch Phys Med Rehabil</source><year>2011</year><volume>92</volume><fpage>S20</fpage><lpage>S27</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2010.08.033</pub-id><pub-id pub-id-type="pmid">21958919</pub-id><pub-id pub-id-type="pmcid">PMC3696589</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Lai J, Cella D, Choi S et al (2011) How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMISE fatigue item bank example. Arch Phys Med Rehabil 92:S20&#8211;S27<pub-id pub-id-type="pmid">21958919</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.apmr.2010.08.033</pub-id><pub-id pub-id-type="pmcid">PMC3696589</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yanez</surname><given-names>B</given-names></name><name name-style="western"><surname>Pearman</surname><given-names>T</given-names></name><name name-style="western"><surname>Lis</surname><given-names>CG</given-names></name><name name-style="western"><surname>Beaumont</surname><given-names>JL</given-names></name><name name-style="western"><surname>Cella</surname><given-names>D</given-names></name></person-group><article-title>The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research</article-title><source>Ann Oncol</source><year>2013</year><volume>24</volume><issue>4</issue><fpage>1073</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/annonc/mds539</pub-id><pub-id pub-id-type="pmid">23136235</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Yanez B, Pearman T, Lis CG, Beaumont JL, Cella D (2013) The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Ann Oncol 24(4):1073&#8211;8. 10.1093/annonc/mds539<pub-id pub-id-type="pmid">23136235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/annonc/mds539</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>PM</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>A</given-names></name></person-group><article-title>Multilingual Miami: current trends in sociolinguistic research</article-title><source>Language Linguist Compass</source><year>2015</year><volume>9</volume><issue>9</issue><fpage>369</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1111/lnc3.12157</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Carter PM, Lynch A (2015) Multilingual Miami: current trends in sociolinguistic research. Language Linguist Compass 9(9):369&#8211;385</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>GR</given-names></name><name name-style="western"><surname>Deal</surname><given-names>AM</given-names></name><name name-style="western"><surname>Sanoff</surname><given-names>HK</given-names></name><etal/></person-group><article-title>Frailty and health-related quality of life in older women with breast cancer</article-title><source>Support Care Cancer</source><year>2019</year><volume>27</volume><issue>7</issue><fpage>2693</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/s00520-018-4558-6</pub-id><pub-id pub-id-type="pmid">30484012</pub-id><pub-id pub-id-type="pmcid">PMC6536366</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Williams GR, Deal AM, Sanoff HK et al (2019) Frailty and health-related quality of life in older women with breast cancer. Support Care Cancer 27(7):2693&#8211;98. 10.1007/s00520-018-4558-6<pub-id pub-id-type="pmid">30484012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00520-018-4558-6</pub-id><pub-id pub-id-type="pmcid">PMC6536366</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ness</surname><given-names>KK</given-names></name><name name-style="western"><surname>Wogksch</surname><given-names>MD</given-names></name></person-group><article-title>Frailty and aging in cancer survivors</article-title><source>Transl Res</source><year>2020</year><volume>221</volume><fpage>65</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2020.03.013</pub-id><pub-id pub-id-type="pmid">32360946</pub-id><pub-id pub-id-type="pmcid">PMC7321876</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Ness KK, Wogksch MD (2020) Frailty and aging in cancer survivors. Transl Res 221:65&#8211;82. 10.1016/j.trsl.2020.03.013<pub-id pub-id-type="pmid">32360946</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.trsl.2020.03.013</pub-id><pub-id pub-id-type="pmcid">PMC7321876</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watts</surname><given-names>S</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>P</given-names></name><name name-style="western"><surname>Mason</surname><given-names>J</given-names></name><name name-style="western"><surname>McLeod</surname><given-names>N</given-names></name><name name-style="western"><surname>Lewith</surname><given-names>G</given-names></name></person-group><article-title>Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates</article-title><source>BMJ Open</source><year>2015</year><volume>5</volume><issue>11</issue><fpage>e007618</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2015-007618</pub-id><pub-id pub-id-type="pmid">26621509</pub-id><pub-id pub-id-type="pmcid">PMC4679843</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Watts S, Prescott P, Mason J, McLeod N, Lewith G (2015) Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 5(11):e007618. 10.1136/bmjopen-2015-007618<pub-id pub-id-type="pmid">26621509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2015-007618</pub-id><pub-id pub-id-type="pmcid">PMC4679843</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linden</surname><given-names>W</given-names></name><name name-style="western"><surname>Vodermaier</surname><given-names>A</given-names></name><name name-style="western"><surname>Mackenzie</surname><given-names>R</given-names></name><name name-style="western"><surname>Greig</surname><given-names>D</given-names></name></person-group><article-title>Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age</article-title><source>J Affect Disord</source><year>2012</year><volume>141</volume><issue>2&#8211;3</issue><fpage>343</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2012.03.025</pub-id><pub-id pub-id-type="pmid">22727334</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Linden W, Vodermaier A, Mackenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2&#8211;3):343&#8211;51. 10.1016/j.jad.2012.03.025<pub-id pub-id-type="pmid">22727334</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jad.2012.03.025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inhestern</surname><given-names>L</given-names></name><name name-style="western"><surname>Beierlein</surname><given-names>V</given-names></name><name name-style="western"><surname>Bultmann</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Anxiety and depression in working-age cancer survivors: a register-based study</article-title><source>BMC Cancer</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>347</fpage><pub-id pub-id-type="doi">10.1186/s12885-017-3347-9</pub-id><pub-id pub-id-type="pmid">28526007</pub-id><pub-id pub-id-type="pmcid">PMC5438539</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Inhestern L, Beierlein V, Bultmann JC et al (2017) Anxiety and depression in working-age cancer survivors: a register-based study. BMC Cancer 17(1):347. 10.1186/s12885-017-3347-9<pub-id pub-id-type="pmid">28526007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-017-3347-9</pub-id><pub-id pub-id-type="pmcid">PMC5438539</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schlumbrecht</surname><given-names>MP</given-names></name><name name-style="western"><surname>Sun</surname><given-names>CC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>MS</given-names></name><name name-style="western"><surname>Zandstra</surname><given-names>F</given-names></name><name name-style="western"><surname>Bodurka</surname><given-names>DC</given-names></name></person-group><article-title>Lifestyle modification in cervical cancer survivors: an ongoing need</article-title><source>Int J Gynecol Cancer</source><year>2014</year><volume>24</volume><issue>3</issue><fpage>570</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1097/igc.0000000000000081</pub-id><pub-id pub-id-type="pmid">24469324</pub-id><pub-id pub-id-type="pmcid">PMC4279702</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Schlumbrecht MP, Sun CC, Huang MS, Zandstra F, Bodurka DC (2014) Lifestyle modification in cervical cancer survivors: an ongoing need. Int J Gynecol Cancer 24(3):570&#8211;5. 10.1097/igc.0000000000000081<pub-id pub-id-type="pmid">24469324</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/IGC.0000000000000081</pub-id><pub-id pub-id-type="pmcid">PMC4279702</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Read</surname><given-names>SH</given-names></name><name name-style="western"><surname>Moino</surname><given-names>D</given-names></name><name name-style="western"><surname>Ayoubi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chern</surname><given-names>JY</given-names></name><name name-style="western"><surname>Tworoger</surname><given-names>SS</given-names></name></person-group><article-title>Tobacco smoking and survival following a diagnosis with ovarian cancer</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2022</year><volume>31</volume><issue>7</issue><fpage>1376</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.Epi-21-1327</pub-id><pub-id pub-id-type="pmid">35775222</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Wang T, Read SH, Moino D, Ayoubi Y, Chern JY, Tworoger SS (2022) Tobacco smoking and survival following a diagnosis with ovarian cancer. Cancer Epidemiol Biomarkers Prev 31(7):1376&#8211;82. 10.1158/1055-9965.Epi-21-1327<pub-id pub-id-type="pmid">35775222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1055-9965.EPI-21-1327</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smits</surname><given-names>A</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>A</given-names></name><name name-style="western"><surname>Bekkers</surname><given-names>R</given-names></name><name name-style="western"><surname>Galaal</surname><given-names>K</given-names></name></person-group><article-title>Body mass index and the quality of life of endometrial cancer survivors&#8211;a systematic review and meta-analysis</article-title><source>Gynecol Oncol</source><year>2015</year><volume>137</volume><issue>1</issue><fpage>180</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2015.01.540</pub-id><pub-id pub-id-type="pmid">25636459</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Smits A, Lopes A, Bekkers R, Galaal K (2015) Body mass index and the quality of life of endometrial cancer survivors&#8211;a systematic review and meta-analysis. Gynecol Oncol 137(1):180&#8211;7. 10.1016/j.ygyno.2015.01.540<pub-id pub-id-type="pmid">25636459</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2015.01.540</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>HQ</given-names></name><name name-style="western"><surname>Armer</surname><given-names>J</given-names></name><etal/></person-group><article-title>GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: the impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function</article-title><source>Gynecol Oncol</source><year>2021</year><volume>160</volume><issue>1</issue><fpage>244</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2020.10.023</pub-id><pub-id pub-id-type="pmid">33109392</pub-id><pub-id pub-id-type="pmcid">PMC7779696</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Carter J, Huang HQ, Armer J et al (2021) GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: the impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecol Oncol 160(1):244&#8211;51. 10.1016/j.ygyno.2020.10.023<pub-id pub-id-type="pmid">33109392</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2020.10.023</pub-id><pub-id pub-id-type="pmcid">PMC7779696</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mishra</surname><given-names>SI</given-names></name><name name-style="western"><surname>Scherer</surname><given-names>RW</given-names></name><name name-style="western"><surname>Geigle</surname><given-names>PM</given-names></name><etal/></person-group><article-title>2012 Exercise interventions on health-related quality of life for cancer survivors</article-title><source>Cochrane Database Syst Rev</source><year>2012</year><volume>8</volume><fpage>Cd007566</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD007566.pub2</pub-id><pub-id pub-id-type="pmcid">PMC7387117</pub-id><pub-id pub-id-type="pmid">22895961</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Mishra SI, Scherer RW, Geigle PM et al (2012) 2012 Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev 8:Cd007566. 10.1002/14651858.CD007566.pub2<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD007566.pub2</pub-id><pub-id pub-id-type="pmcid">PMC7387117</pub-id><pub-id pub-id-type="pmid">22895961</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ditre</surname><given-names>JW</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>BD</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>VN</given-names></name><name name-style="western"><surname>Faul</surname><given-names>LA</given-names></name><name name-style="western"><surname>Brandon</surname><given-names>TH</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>PB</given-names></name></person-group><article-title>Associations between pain and current smoking status among cancer patients</article-title><source>Pain</source><year>2011</year><volume>152</volume><issue>1</issue><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2010.09.001</pub-id><pub-id pub-id-type="pmid">21168758</pub-id><pub-id pub-id-type="pmcid">PMC3031140</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Ditre JW, Gonzalez BD, Simmons VN, Faul LA, Brandon TH, Jacobsen PB (2011) Associations between pain and current smoking status among cancer patients. Pain 152(1):60&#8211;65. 10.1016/j.pain.2010.09.001<pub-id pub-id-type="pmid">21168758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pain.2010.09.001</pub-id><pub-id pub-id-type="pmcid">PMC3031140</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubinsak</surname><given-names>LA</given-names></name><name name-style="western"><surname>Kang</surname><given-names>L</given-names></name><name name-style="western"><surname>Fields</surname><given-names>EC</given-names></name><name name-style="western"><surname>Carter</surname><given-names>JS</given-names></name><name name-style="western"><surname>McGuire</surname><given-names>WP</given-names></name><name name-style="western"><surname>Temkin</surname><given-names>SM</given-names></name></person-group><article-title>Treatment-related radiation toxicity among cervical cancer patients</article-title><source>Int J Gynecol Cancer</source><year>2018</year><volume>28</volume><issue>7</issue><fpage>1387</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1097/igc.0000000000001309</pub-id><pub-id pub-id-type="pmid">30036222</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Rubinsak LA, Kang L, Fields EC, Carter JS, McGuire WP, Temkin SM (2018) Treatment-related radiation toxicity among cervical cancer patients. Int J Gynecol Cancer 28(7):1387&#8211;93. 10.1097/igc.0000000000001309<pub-id pub-id-type="pmid">30036222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/IGC.0000000000001309</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;nez</surname><given-names>&#218;</given-names></name><name name-style="western"><surname>Brandon</surname><given-names>KO</given-names></name><name name-style="western"><surname>Sutton</surname><given-names>SK</given-names></name><name name-style="western"><surname>Brandon</surname><given-names>TH</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>VN</given-names></name></person-group><article-title>Does smoking abstinence predict cancer patients&#8217; quality of life over time?</article-title><source>Psychooncology</source><year>2019</year><volume>28</volume><issue>8</issue><fpage>1702</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1002/pon.5145</pub-id><pub-id pub-id-type="pmid">31212391</pub-id><pub-id pub-id-type="pmcid">PMC6691965</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Mart&#237;nez &#218;, Brandon KO, Sutton SK, Brandon TH, Simmons VN (2019) Does smoking abstinence predict cancer patients&#8217; quality of life over time? Psychooncology 28(8):1702&#8211;11. 10.1002/pon.5145<pub-id pub-id-type="pmid">31212391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pon.5145</pub-id><pub-id pub-id-type="pmcid">PMC6691965</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malagon-Blackwell</surname><given-names>EM</given-names></name><name name-style="western"><surname>Seagle</surname><given-names>BL</given-names></name><name name-style="western"><surname>Nieves-Neira</surname><given-names>W</given-names></name><name name-style="western"><surname>Shahabi</surname><given-names>S</given-names></name></person-group><article-title>The hispanic paradox in endometrial cancer: a national cancer database study</article-title><source>Gynecol Oncol</source><year>2017</year><volume>146</volume><issue>2</issue><fpage>351</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2017.05.026</pub-id><pub-id pub-id-type="pmid">28549815</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Malagon-Blackwell EM, Seagle BL, Nieves-Neira W, Shahabi S (2017) The hispanic paradox in endometrial cancer: a national cancer database study. Gynecol Oncol 146(2):351&#8211;58. 10.1016/j.ygyno.2017.05.026<pub-id pub-id-type="pmid">28549815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2017.05.026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Bureau USC (2023) Miami Dade county census quick facts. Secondary Miami Dade County Census Quick Facts 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.census.gov/quickfacts/fact/table/miamidadecountyflorida#">https://www.census.gov/quickfacts/fact/table/miamidadecountyflorida#</ext-link></mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diamond</surname><given-names>L</given-names></name><name name-style="western"><surname>Izquierdo</surname><given-names>K</given-names></name><name name-style="western"><surname>Canfield</surname><given-names>D</given-names></name><name name-style="western"><surname>Matsoukas</surname><given-names>K</given-names></name><name name-style="western"><surname>Gany</surname><given-names>F</given-names></name></person-group><article-title>A systematic review of the impact of patient-physician non-english language concordance on quality of care and outcomes</article-title><source>J Gen Intern Med</source><year>2019</year><volume>34</volume><issue>8</issue><fpage>1591</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1007/s11606-019-04847-5</pub-id><pub-id pub-id-type="pmid">31147980</pub-id><pub-id pub-id-type="pmcid">PMC6667611</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Diamond L, Izquierdo K, Canfield D, Matsoukas K, Gany F (2019) A Systematic review of the impact of patient-physician non-english language concordance on quality of care and outcomes. J Gen Intern Med 34(8):1591&#8211;606. 10.1007/s11606-019-04847-5<pub-id pub-id-type="pmid">31147980</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-019-04847-5</pub-id><pub-id pub-id-type="pmcid">PMC6667611</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saha</surname><given-names>S</given-names></name><name name-style="western"><surname>Komaromy</surname><given-names>M</given-names></name><name name-style="western"><surname>Koepsell</surname><given-names>TD</given-names></name><name name-style="western"><surname>Bindman</surname><given-names>AB</given-names></name></person-group><article-title>Patient-physician racial concordance and the perceived quality and use of health care</article-title><source>Arch Intern Med</source><year>1999</year><volume>159</volume><issue>9</issue><fpage>997</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1001/archinte.159.9.997</pub-id><pub-id pub-id-type="pmid">10326942</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Saha S, Komaromy M, Koepsell TD, Bindman AB (1999) Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med 159(9):997&#8211;1004. 10.1001/archinte.159.9.997<pub-id pub-id-type="pmid">10326942</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinte.159.9.997</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seible</surname><given-names>DM</given-names></name><name name-style="western"><surname>Kundu</surname><given-names>S</given-names></name><name name-style="western"><surname>Azuara</surname><given-names>A</given-names></name><etal/></person-group><article-title>The influence of patient-provider language concordance in cancer care: results of the Hispanic outcomes by language approach (HOLA) randomized trial</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2021</year><volume>111</volume><issue>4</issue><fpage>856</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2021.05.122</pub-id><pub-id pub-id-type="pmid">34058256</pub-id><pub-id pub-id-type="pmcid">PMC9137326</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Seible DM, Kundu S, Azuara A et al (2021) The influence of patient-provider language concordance in cancer care: results of the Hispanic outcomes by language approach (HOLA) randomized trial. Int J Radiat Oncol Biol Phys 111(4):856&#8211;64. 10.1016/j.ijrobp.2021.05.122<pub-id pub-id-type="pmid">34058256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijrobp.2021.05.122</pub-id><pub-id pub-id-type="pmcid">PMC9137326</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>